Terms and Conditions for Use of Caldorivexa

By using our AI-based automated trading recommendation platform, users accept the following terms. Please review these conditions before proceeding on caldorivexa.sbs.

Updated on January 6, 2026

Acceptance of Terms

Using Caldorivexa's services constitutes your agreement to these terms and any applicable legal requirements. If you do not agree, discontinue use immediately.

Key Definitions

Below, we clarify the main terms used within this agreement for your understanding.

"Platform" means the caldorivexa.sbs website and any related digital services delivered by the company.

"Recommendations" refers to data-driven, AI-generated suggestions for trade opportunities based on available market information.

"User Data" is any personal or interactional information you provide or generate through usage of our services.

"Service" covers the functionalities of our platform, including automated recommendations and user support.

Conditions of Use

Users must use the platform only as intended, providing accurate details and respecting the integrity of the service.

Eligibility

Access is open to residents 18 years or older in South Africa who have the capacity to contract. No use by minors is permitted.

Verification may be required at sign-up.

User Responsibilities

We expect clients to use our services lawfully and maintain the security of their account credentials.

Provide true and complete information during setup
Keep account credentials confidential and secure
Refrain from using platform for illegal purposes
Promptly notify support of suspicious activity

Prohibited Activities

The following activities are strictly prohibited while using caldorivexa.sbs.

Attempting to access or alter system data without authorization
Using the platform for any fraudulent or deceptive practices
Disrupting service functionality or other users’ experience
Uploading malware, viruses, or other harmful content
Engaging in conduct contrary to South African law

Intellectual Property

All content, code, and algorithms within Caldorivexa are owned or licensed by the company. Use is restricted to personal, non-commercial purposes, and may not be copied, modified, or redistributed.

User Contributions

Any feedback, suggestions, or content submitted can be used for platform improvement under these terms.

User Content Rights

By submitting content, you grant us a license to use, reproduce, or adapt for platform benefit without paid compensation.

Privacy Protection

Personal information is handled in accordance with our Privacy Policy and all relevant data protection laws.

Read Privacy Policy

Important Disclaimers

Caldorivexa offers automated recommendations as a supportive resource only. We do not guarantee performance or specific outcomes.

Market Risks

Financial markets involve risks, and results may vary. Past performance does not predict future results.

Limits of Liability

We are not liable for indirect, incidental, or consequential damages arising from your use of the service.

Indemnification

You agree to defend and indemnify Caldorivexa against claims, losses, or damages from your breach of these terms.

Dispute Resolution Procedure

Any disagreements should be addressed first by contacting support for resolution.

Arbitration

Should informal resolution fail, disputes are subject to confidential arbitration in South Africa.

Arbitrator's decision is final, barring manifest error.

Online Dispute Resolution

If unresolved, users may contact a recognized ombudsman or alternative legal route.

Find out more

Severability

If a term is found invalid, the rest remain effective and enforceable.

Entire Agreement

These Terms and related documents form the entire agreement between user and company.

Jurisdiction and Law

All disputes fall under South African law and exclusive jurisdiction.

Termination

Accounts may be suspended with notice for terms violations. Users can close accounts anytime.

Modifications

Terms may change with notice. Continued use means acceptance of revised conditions.

Contact Information

Questions about these Terms can be directed to our team.

Support Email: content@caldorivexa.sbs

Helpline: +27329996474

Head Office: 80 Strand Street, Cape Town 8000 South Africa

Effective Date: January 6, 2026

Version: 2.0